SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000320017-15-000050
Filing Date
2015-06-08
Accepted
2015-06-08 16:06:14
Documents
3
Period of Report
2015-06-08
Effectiveness Date
2015-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a-2015.htm DEF 14A 1408845
2 caladriuslogo.jpg GRAPHIC 333151
3 vatersbobsig2black.jpg GRAPHIC 6844
  Complete submission text file 0000320017-15-000050.txt   1878919
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33650 | Film No.: 15918566
SIC: 8090 Services-Misc Health & Allied Services, NEC